Nurture & Restore Wellness Inc

08/29/2025

Your immune system is your body’s built-in cancer defense.
Every day, immune cells patrol your body, looking for abnormal or damaged cells — including cancer cells — and eliminating them before they can cause harm.

This constant “immune surveillance” is why many cancers never progress. But tumors are clever: they can hide their identity, switch off immune responses, or create a suppressive microenvironment where immune cells can’t work properly.

The good news? We now have ways to re-activate and guide the immune system back into action. From checkpoint inhibitors to advanced dendritic cell therapies — and by optimizing the body’s terrain through nutrition, lifestyle, and targeted support — we can help restore the immune system’s ability to see and destroy cancer cells.

This isn’t just treatment. It’s teaching the immune system to protect you — for the long term.

08/28/2025

High-dose IV vitamin C works differently from oral vitamin C — reaching blood concentrations that may help selectively stress cancer cells, reduce treatment side effects, and support overall quality of life.

Research is ongoing, but findings suggest benefits when used alongside conventional treatments, especially in reducing fatigue, improving tolerance, and supporting the immune system.

In integrative oncology, IV vitamin C is always individualized — carefully dosed, screened for safety, and coordinated with the patient’s full treatment plan.

08/26/2025

Your microbiome — the trillions of microbes in your gut — is more than a digestive helper. It’s a dynamic ecosystem that communicates with your immune system, influences inflammation, and even affects how well cancer treatments work.

When balanced, it supports health and immune vigilance. When disrupted, it can fuel inflammation and weaken the body’s defenses.

In terrain-based oncology, we actively work to support microbiome health through nutrition, lifestyle, and targeted supplementation — because a healthy microbiome strengthens the body’s overall terrain against cancer.

08/25/2025

Lab markers are like your health’s dashboard — showing us how your body is responding to both cancer and its treatment.

From inflammation markers like CRP and ESR, to nutrient status and organ function, these results help us adjust nutrition, supplementation, and supportive care in real time.

In terrain-based oncology, we don’t just run labs once — we use them as a tool for continuous feedback, ensuring your plan evolves as your needs change.

When treatment decisions are guided by data, care becomes more precise, proactive, and personal.

08/21/2025

Inflammation is essential for healing — but when it becomes chronic, it can quietly shift the body’s terrain toward cancer growth.

Long-term inflammatory signals can damage DNA, suppress immune function, and feed tumor development through processes like angiogenesis (new blood vessel growth).

The good news: chronic inflammation is modifiable. By identifying its root causes — whether metabolic, environmental, infectious, or lifestyle-related — we can take targeted action to restore immune balance and improve the body’s resilience.

This is why in terrain-based oncology, we don’t just look at the tumor. We look at the entire environment it lives in — and we change it.

08/20/2025

Mistletoe (Viscum album) is one of the most widely used integrative therapies in European oncology — with a history of research on its potential to improve quality of life, reduce treatment side effects, and support immune resilience.

It’s typically given as an injection and carefully tailored to each patient, with adjustments in dose and timing based on individual response.

While not a replacement for conventional therapy, mistletoe is valued for its ability to help patients feel stronger, more energized, and better able to tolerate treatment — making it a useful supportive tool in terrain-based oncology.

08/17/2025

Your immune system works in three vital steps: Recognize. Respond. Regulate.

First, it must recognize the threat—specialized immune “generals” identify invaders or abnormal cells.
Next, it responds by mobilizing T-cells, B-cells, and NK cells to carry out the defense.
Finally, it must regulate, shutting down excess inflammation to protect healthy tissue once the danger has passed.

This rhythm of recognition, response, and regulation is essential for lasting health and resilience. When the process is supported and balanced, the body can defend itself without turning its defenses inward.

08/17/2025

Cancer is complex — and so is the human body. No two patients share the same story, the same terrain, or the same response to treatment. Integrative metabolic oncology looks beyond the tumor itself to the whole person, addressing the biological, emotional, and environmental factors that contribute to cancer development and progression.

This approach combines cutting-edge science with personalized, data-driven care, empowering patients to:

Understand the terrain that fuels cancer growth
Support their body’s natural healing processes
Reduce side effects of conventional therapies
Improve overall resilience and long-term outcomes
Optimize and protect around chemotherapy, surgery and radiation

A key part of this process is testing. I use advanced bloodwork, functional medicine panels, hormone and immune assessments, and nutrient mapping to uncover what is driving cancer in each individual. These results allow us to identify imbalances, toxicities, and metabolic patterns that need support. Most importantly, your plan evolves as your body changes — meaning we adjust strategies over time to stay aligned with your unique biology and treatment path.

Send a message to learn more

08/15/2025

Your immune system has two “wanted poster” systems — MHC Class I (for killer T-cells) and MHC Class II (for helper T-cells).

For the most powerful anti-cancer response, both must show the same exact tumor antigen. That perfect match triggers a coordinated, Th1-driven immune attack that’s both precise and powerful.

This isn’t how most dendritic cell therapies work.

Immunocine’s approach is different: we load your dendritic cells with identical, patient-specific tumor antigens on both MHC I and II. The result? A double, perfectly matched signal that fully engages your immune system to target your cancer.

https://pubmed.ncbi.nlm.nih.gov/32298026/
https://pubmed.ncbi.nlm.nih.gov/19171878/

Cancer Center

08/13/2025

“In a 1987 clinical study, high-dose melatonin (20 mg daily) was given to 19 patients with advanced, untreatable solid tumors. Among those with better baseline health, one patient had a partial tumor response, five had stable disease, and six experienced improved performance status. While preliminary, this research hints that melatonin might support quality of life in advanced cancer—especially when standard treatments fail.”

08/12/2025

Cancer doesn’t exist in a vacuum — it grows within a complex “neighborhood” of cells, vessels, and signals called the tumor microenvironment.

This microenvironment can protect cancer, feed it, and shield it from the immune system. But it’s also a potential target for therapy.

By addressing inflammation, oxygenation, nutrient balance, and immune suppression within the tumor’s surroundings, we can shift the terrain from one that supports cancer growth to one that actively resists it.

This is why in terrain-based oncology, we don’t just target the tumor — we transform its environment.

08/11/2025

Fasting is more than a wellness trend — it’s a metabolic strategy being studied for its potential to make cancer treatments more effective and gentler on the body.

Healthy cells adapt to fasting by conserving energy and repairing. Many cancer cells can’t make that switch, potentially making them more sensitive to treatment.

During cancer care, timing, safety, and medical supervision are essential. Please consult your care team.

https://pubmed.ncbi.nlm.nih.gov/33053285/

Dr. Nasha Winters, ND, FABNO Metabolic Terrain Institute Of Health